|Articles|July 30, 2015
Video: CFO Simon Dingemans on GSK's Q2 Results
July 30, 2015.
Advertisement
In this video
, GlaxoSmithKline CFO Simon Dingemans relays the company's Q2 2015 results, rhe first since the Novartis transaction closed. Despite a slide in the sales of lung drug Advair and lower profit margins following a business revamp, Dingemans says sales rose during the period and that newly acquired businesses are performing in line with expectations.
http://www.3bnexus.com/portal/video/6hdb24abf34c8cc
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma
4
Sobi Reaches $1.5 Billion Definitive Agreement with Arthrosi Therapeutics to Acquire Gout Treatment
5
